Posts Tagged ‘Guidant’

Judge Holds Off Ruling After Boston Scientific Admits Hiding Problems With Implantable Heart Defibrillators

Judge Holds Off Ruling After Boston Scientific Admits Hiding Problems With Implantable Heart Defibrillators

Courtesy of Mish 

Boston Scientific admits it failed to disclose short-circuiting problems with its defibrillators. Some users died as a result. But hey, anything for a profit, especially when penalties are low. Please consider Judge Holds Off Boston Scientific Unit Plea in Probe.

A federal judge reserved ruling on a guilty plea by Boston Scientific Corp.’s Guidant unit to charges it hid problems with its implantable heart defibrillators, citing objections raised by plaintiffs suing the company.

U.S. District Judge Donovan Frank in St. Paul, Minnesota, said today he will rule on the plea and a related settlement within three weeks when he decides whether to put the company on probation and order restitution.

The medical device-maker agreed to plead guilty to two misdemeanors for excluding defibrillator-malfunction reports from product updates sent to doctors and failing to alert the U.S. Food and Drug Administration to the defects. Boston Scientific agreed to pay $296 million in November to settle a U.S. Justice Department probe of the unit’s handling of the devices.

Prosecutors said in court papers that Guidant officials learned as early as 2002 that some of the defibrillators had short-circuiting problems that led to some users’ deaths. The company didn’t disclose the defects for more than three years, the government added in the filings.

Last month, Boston Scientific halted all sales of heart-rhythm devices because of an erroneous filing with regulators.

“When a corporation who makes life-saving devices lies to the FDA, that puts the implantees and others at risk,” Charles Zimmerman, an attorney for plaintiffs, said during today’s hearing. “Today Guidant comes before the court and asks you to accept a plea of guilty in which they admit they have lied.”

Boston Scientific’s shares fell the most in 17 months on March 15 after the company said it stopped sales of defibrillators because of a documentation error. The devices brought in $1.79 billion last year, or 22 percent of Boston Scientific’s revenue, according to data compiled by Bloomberg.

The company’s heart pacemakers and defibrillators are implanted in patients’ bodies to shock hearts back into normal rhythm.

Earlier today I commented that Pfizer Caught Illegally Marketing Bextra. However, the Feds would not prosecute because "Pfizer Is Too Big To Nail".

Pfizer got off with a fine, while Boston Scientific plead guilty to…
continue reading


Tags: , , ,




 
 
 

Zero Hedge

"Black People Don't Have To Be Democrats": Obama-Linked Rapper Backs Kanye As MSM Melts Down Over MAGA

Courtesy of ZeroHedge. View original post here.

Kanye West pal and fellow Chicago-based musician "Chance the Rapper" fired off a tweet in support of his controversial friend, who is once again taking flack from the left over his love of Donald Trump - and most recently, black conservative Candace Owens

"Black people don't have to be democrats," tweeted the 25-year-old Chance in defense of Kanye. 

Black people don’t have to be democrat...



more from Tyler

Phil's Favorites

The hypodermic effect: How propaganda manipulates our emotions

 

The hypodermic effect: How propaganda manipulates our emotions

Facebook CEO Mark Zuckerberg departs after testifying on Capitol Hill in Washington, D.C., in April 2018 about the use of Facebook data to target American voters in the 2016 presidential election and data privacy. (AP Photo/Andrew Harnik)

Courtesy of Isaac Nahon-Serfaty, University of Ottawa

The scandal surrounding the improper use of data by Cambridge Analytica and Facebook in the 2016 U.S. election is reminiscent of the old debates about propagand...



more from Ilene

Chart School

S&P To Test 200-day MA

Courtesy of Declan

After yesterday's selling today's late recovery was a chance for bulls to catch some breadth.

The S&P came close to tagging the 200-day MA on the intraday low. The index is on a path to the lower channel. There was no technical change and relative performance remains weak.
 


The Nasdaq stalled mid-decline. Today's doji did not appear at a natural support level and the 200-day MA still looks the better support test but aggressive longs may try fish for a position here with a stop on a loss of 6,926.
...



more from Chart School

Digital Currencies

Crypto Billionaire Sued By VC Giant Sequoia Over Collapsed Funding Deal

Courtesy of ZeroHedge. View original post here.

By Marie Huillet, CoinTelegraph.com

Venture capital firm Sequoia is suing Zhao Changpeng, the CEO and founder of Binance, currently the world’s largest cryptocurrency exchange by trade volume, for allege...



more from Bitcoin

Insider Scoop

Earnings Scheduled For April 25, 2018

Courtesy of Benzinga.

Companies Reporting Before The Bell
  • Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
  • Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
  • Twitter, Inc. ...


http://www.insidercow.com/ more from Insider

Biotech

Why marijuana fans should not see approval for epilepsy drug as a win for weed

Reminder: Pharmboy and Ilene are available to chat with Members, comments are found below each post.

 

Why marijuana fans should not see approval for epilepsy drug as a win for weed

Small vials of CBD, which some believe could be a cure for many ailments. Roxana Gonzalez/Shutterstock.com

Courtesy of Timothy Welty, Drake University

A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on Ap...



more from Biotech

ValueWalk

Buffett At His Best

By csinvesting. Originally published at ValueWalk.

Bear with me as I share a bit of my history that helped me create SkyVu and the Battle Bears games. The University of Nebraska gave me my first job after college. I mostly pushed TV carts around, edited videos for professors or the occasional speaker event. One day, Warren Buffet came to campus to speak to the College of Business. I didn’t think much of this speech at the time but I saved it for some reason. 15 years later, as a founder of my own company, I watch and listen to this particular speech every year to remind myself of the fundamentals and values Mr. Buffett looks for. He’s addressing business students at his alma mater, so I think his style here is a bit more ‘close to home’ than in his other speeches. Hopefully many of you find great value in this video like I have. Sorry for the VHS...



more from ValueWalk

Kimble Charting Solutions

The Stock Bull Market Stops Here!

 

The Stock Bull Market Stops Here!

Courtesy of Kimble Charting

 

The definition of a bull market or bull trends widely vary. One of the more common criteria for bull markets is determined by the asset being above or below its 200 day moving average.

In my humble opinion, each index above remains in a bull trend, as triple support (200-day moving averages, 2-year rising support lines, and February lows) are still in play ...



more from Kimble C.S.

Members' Corner

Cambridge Analytica and the 2016 Election: What you need to know (updated)

 

"If you want to fundamentally reshape society, you first have to break it." ~ Christopher Wylie

[Interview: Cambridge Analytica whistleblower: 'We spent $1m harvesting millions of Facebook profiles' – video]

"You’ve probably heard by now that Cambridge Analytica, which is backed by the borderline-psychotic Mercer family and was formerly chaired by Steve Bannon, had a decisive role in manipulating voters on a one-by-one basis – using their own personal data to push them toward voting ...



more from Our Members

Mapping The Market

The tricks propagandists use to beat science

Via Jean-Luc

How propagandist beat science – they did it for the tobacco industry and now it's in favor of the energy companies:

The tricks propagandists use to beat science

The original tobacco strategy involved several lines of attack. One of these was to fund research that supported the industry and then publish only the results that fit the required narrative. “For instance, in 1954 the TIRC distributed a pamphlet entitled ‘A Scientific Perspective on the Cigarette Controversy’ to nearly 200,000 doctors, journalists, and policy-makers, in which they emphasized favorable research and questioned results supporting the contrary view,” say Weatherall and co, who call this approach biased production.

A second approach promoted independent research that happened to support ...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

NewsWare: Watch Today's Webinar!

 

We have a great guest at today's webinar!

Bill Olsen from NewsWare will be giving us a fun and lively demonstration of the advantages that real-time news provides. NewsWare is a market intelligence tool for news. In today's data driven markets, it is truly beneficial to have a tool that delivers access to the professional sources where you can obtain the facts in real time.

Join our webinar, free, it's open to all. 

Just click here at 1 pm est and join in!

[For more information on NewsWare, click here. For a list of prices: NewsWar...



more from Promotions

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>